Pay Attention to this Trade Activity as Novabay Pharmaceuticals Inc (NBY) last week performance was -24.96%

As on Wednesday, Novabay Pharmaceuticals Inc (AMEX: NBY) got off with the flyer as it spiked 0.10% to $0.10, before settling in for the price of $0.10 at the close. Taking a more long-term approach, NBY posted a 52-week range of $0.10-$1.95.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 9.88%. Meanwhile, its Annual Earning per share during the time was 24.47%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 89.65%. This publicly-traded company’s shares outstanding now amounts to $30.10 million, simultaneously with a float of $29.36 million. The organization now has a market capitalization sitting at $3.14 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1441, while the 200-day Moving Average is $0.3880.

Novabay Pharmaceuticals Inc (NBY) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Novabay Pharmaceuticals Inc’s current insider ownership accounts for 2.44%, in contrast to 3.95% institutional ownership.

Novabay Pharmaceuticals Inc (NBY) Earnings and Revenue Records

If we go through the results of last quarter, which was made public on 12/30/2023, the company posted -$1.33 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -$0.3) by -$1.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.

Novabay Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 89.65% and is forecasted to reach 0.07 in the upcoming year.

Novabay Pharmaceuticals Inc (AMEX: NBY) Trading Performance Indicators

Let’s observe the current performance indicators for Novabay Pharmaceuticals Inc (NBY). It’s Quick Ratio in the last reported quarter now stands at 1.00. The Stock has managed to achieve an average true range (ATR) of 0.01. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.21.

In the same vein, NBY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.31, a figure that is expected to reach -0.25 in the next quarter, and analysts are predicting that it will be 0.07 at the market close of one year from today.

Technical Analysis of Novabay Pharmaceuticals Inc (NBY)

Through scrutinizing the latest numbers posted by the [Novabay Pharmaceuticals Inc, NBY], it can be observed that its last 5-days Average volume of 2.89 million was lower the volume of 3.56 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 8.57% While, its Average True Range was 0.0109.

Raw Stochastic average of Novabay Pharmaceuticals Inc (NBY) in the period of the previous 100 days is set at 1.58%, which indicates a major fall in contrast to 8.23% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 103.33% that was higher than 84.30% volatility it exhibited in the past 100-days period.